Form 4: Carlisle Officer Receives Future Equity Grant

Sentiment:

Insider Transaction Report


Carlisle Companies Inc.'s VP & Chief Accounting Officer, Andrew C. Easton, was granted 225 restricted shares and options for 780 common shares, effective January 28, 2026.

Summary

  • Andrew C. Easton, VP & Chief Accounting Officer of Carlisle Companies Inc. (CSL), was granted 225 shares of common stock.
  • These 225 shares are restricted shares, acquired at a price of $0.
  • Easton was also granted 780 employee stock options (right to buy) for common stock.
  • The exercise price for these options is $341.01 per share, and they were acquired at a price of $0.
  • The transaction date for both grants is January 28, 2026.
  • The options will vest in three equal annual installments, beginning on January 28, 2027, and expire on January 27, 2036.
  • Following these transactions, Easton will beneficially own 772 shares of common stock directly and 780 derivative securities (options) directly.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive development, reflecting standard executive compensation practices that align management incentives with shareholder interests, without indicating any significant new operational or financial news.

Positives

  • The equity grants align the executive's interests with those of shareholders, incentivizing long-term performance.
  • The grants serve as a retention mechanism for a key executive, the VP & Chief Accounting Officer.

Risks

  • The value of the granted restricted shares and stock options is subject to future fluctuations in Carlisle Companies Inc.'s stock price.
  • The options' value is dependent on the stock price exceeding the exercise price of $341.01.
  • Vesting conditions mean the executive must remain employed for a specified period to fully realize the benefits of the grants.

Future Outlook

The employee stock options are scheduled to vest in three equal annual installments, commencing on January 28, 2027, and will expire on January 27, 2036. The realization of value from these grants is contingent on future stock performance and continued employment.

Management Comments

  • The grants were made pursuant to a contract, instruction, or written plan for the purchase or sale of equity securities of the issuer, intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Industry Context

StockSavvy.ai notes that executive equity grants, such as restricted stock and stock options, are a standard and widely adopted practice across various industries. These grants are primarily used to align the long-term interests of key management personnel with those of the company's shareholders, fostering a focus on sustained value creation and executive retention.

Comparison to Industry Standards

  • The use of restricted stock and stock options for executive compensation is a common practice, consistent with compensation structures observed in many publicly traded companies across diverse sectors.
  • The vesting schedule for options (three equal annual installments) is a typical approach designed to encourage long-term commitment and performance from executives.
  • The grant of equity at a $0 acquisition price is standard for compensation awards, differentiating it from open market purchases.

Related Party Transactions

  • The grant of 225 restricted shares and 780 employee stock options to Andrew C. Easton, an executive officer, constitutes a related party transaction as it involves compensation from the issuer to a key management personnel.

Stakeholder Impact

  • Shareholders: Potential positive impact through enhanced alignment of executive interests with long-term company performance and value creation.
  • Employees: No direct impact on general employees, but reinforces the company's executive compensation structure.

Next Steps

  • The vesting of the 780 employee stock options will commence on January 28, 2027, in three equal annual installments.

Key Dates

DateDescription
01/29/2025Date the Form 4 was filed.
01/28/2026Date of the grant for both restricted shares and employee stock options.
01/28/2027Date when the employee stock options begin to vest in three equal annual installments.
01/27/2036Expiration date of the employee stock options.

Recommendation

hold

This Form 4 reports a routine equity grant to a key executive, which is a standard compensation practice. It does not provide new information that would alter the fundamental investment thesis for Carlisle Companies Inc., thus a 'hold' recommendation remains appropriate based solely on this filing.

Keywords

Carlisle Companies, CSL, Andrew C. Easton, Form 4, executive compensation, restricted stock, stock options, insider transaction, equity grant

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.